Taikang Asset Management Hong Kong Co Ltd has purchased 2,858 shares in Axon Enterprise, Inc, valued at around $1,503,000, according to a recent SEC filing. This move highlights a growing trend of institutional interest in the biotechnology firm and reflects broader market engagement with Axon’s business potential.